|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine (Dr. Varon), Baylor College of Medicine, Houston TX; and the Department of Internal Medicine, Section of Critical Care (Dr. Marik), Washington Hospital Center, Washington, DC.
Correspondence to: Joseph Varon, MD, FCCP, Research Director, Department of Emergency Services, The Methodist Hospital, 6565 Fannin M 196, Houston, TX 77030; e-mail: jvaron{at}bcm.tmc.edu
Severe hypertension is a common clinical problem in the United States, encountered in various clinical settings. Although various terms have been applied to severe hypertension, such as hypertensive crises, emergencies, or urgencies, they are all characterized by acute elevations in BP that may be associated with end-organ damage (hypertensive crisis). The immediate reduction of BP is only required in patients with acute end-organ damage. Hypertension associated with cerebral infarction or intracerebral hemorrhage only rarely requires treatment. While nitroprusside is commonly used to treat severe hypertension, it is an extremely toxic drug that should only be used in rare circumstances. Furthermore, the short-acting calcium channel blocker nifedipine is associated with significant morbidity and should be avoided. Today, a wide range of pharmacologic alternatives are available to the practitioner to control severe hypertension. This article reviews some of the current concepts and common misconceptions in the management of patients with acutely elevated BP.
Key Words: aortic dissection ß-blockers calcium channel blockers fenoldopam hypertension hypertensive crises hypertensive encephalopathy labetalol nicardipine nitroprusside pregnancy
This article has been cited by other articles:
![]() |
K. O. Rynn, F. L. Hughes, and B. Faley An Emergency Department Approach to Drug Treatment of Hypertensive Urgency and Emergency Journal of Pharmacy Practice, October 1, 2005; 18(5): 363 - 376. [Abstract] [PDF] |
||||
![]() |
J. E Tisdale, M. B Huang, and S. Borzak Risk factors for hypertensive crisis: importance of out-patient blood pressure control Fam. Pract., August 1, 2004; 21(4): 420 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Devlin, M. L Seta, S. Kanji, and A. L Somerville Fenoldopam Versus Nitroprusside for the Treatment of Hypertensive Emergency Ann. Pharmacother., May 1, 2004; 38(5): 755 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Howell, J. W. Sear, and P. Foex Hypertension, hypertensive heart disease and perioperative cardiac risk{dagger} Br. J. Anaesth., April 1, 2004; 92(4): 570 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Harrington Managing Hypertension in Patients With Stroke: Are You Prepared for Labetalol Infusion? Crit. Care Nurse, June 1, 2003; 23(3): 30 - 38. [Full Text] [PDF] |
||||
![]() |
M. E. Doyle and J. M. Egan Pharmacological Agents That Directly Modulate Insulin Secretion Pharmacol. Rev., March 1, 2003; 55(1): 105 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. POPPAS and S. ROUNDS Congestive Heart Failure Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 4 - 8. [Full Text] [PDF] |
||||
![]() |
G. W. Frank, J. Varon, R. E. Fromm Jr, and P. E. Marik Diazoxide and Trimethaphan Used? Chest, January 1, 2001; 119(1): 316 - 316. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |